M&A Deal Summary

OriGene Technologies Acquires SDIX - Life Science Business

On April 8, 2013, OriGene Technologies acquired life science company SDIX - Life Science Business from Strategic Diagnostics for 16M USD

Acquisition Highlights
  • This is OriGene Technologies’ 2nd transaction in the Life Science sector.
  • This is OriGene Technologies’ largest (disclosed) transaction.
  • This is OriGene Technologies’ 2nd transaction in the United States.

M&A Deal Summary
Date 2013-04-08
Target SDIX - Life Science Business
Sector Life Science
Buyer(s) OriGene Technologies
Sellers(s) Strategic Diagnostics
Deal Type Divestiture
Deal Value 16M USD

Target

SDIX - Life Science Business

United States

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

OriGene Technologies

Rockville, Maryland, United States
Category Company
Founded 1996
Sector Life Science
DESCRIPTION

OriGene Technologies is a gene-centric life sciences company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery. OriGene Technologies was founded in 1996 and is based in Rockville, Maryland.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Divestiture) 1 of 1
Country (United States) 2 of 2
Year (2013) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-08-12 Blue Heron Biotechnology

Bothell, Washington, United States

Blue Heron Biotechnology, Inc. is a company specializing in advanced gene synthesis. Blue Heron Biotechnology was founded in 1999 and is based in Bothell, Washington.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-08-06 Blue Heron Biotechnology

Bothell, Washington, United States

Blue Heron Biotechnology, Inc. is a company specializing in advanced gene synthesis. Blue Heron Biotechnology was founded in 1999 and is based in Bothell, Washington.

Sell -

Seller(S) 1

SELLER

Strategic Diagnostics

Newark, Delaware, United States
Category Company
Founded 1990
Sector Healthcare Services
DESCRIPTION

Strategic Diagnostics is a developer and manufacturer of immunoassay-based test kits for both field testing and laboratory use. These products are used extensively for contaminated waste site assessment and remediation, water quality management, food labeling and transgenic crop seed production.

DEAL STATS #
Overall 3 of 3
Sector (Life Science) 1 of 1
Type (Divestiture) 3 of 3
Country (United States) 3 of 3
Year (2013) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-01 SDIX - Food Safety Business

United States

SDIX Food Safety Business includes RapidChek lateral flow test strips with proprietary enrichment media, the patented RapidChek SELECT phage-based enrichment systems and RapidChek CONFIRM immunomagnetic confirmation tools.

Sell -
Mergr

Product

Company

Legal